Research output per year
Research output per year
Personal profile
Research interests
Drug Utilisation Research and Pharmacoepidemiology, diabetes & cardiovascular treatment. Prescribing quality and indicators. Medication adherence. Shared decision making and decision support tools.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes (T2D) in Indonesia: a cross-sectional survey study
Oktora, M. P., Yuniar, C. T., Amalia, L., Abdulah, R., Hak, E. & Denig, P., 12-Jan-2023, In: BMC Geriatrics. 23, 1, 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure) -
Pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among people with type 2 diabetes
Crutzen, S., Baas, G., Denig, P., Heringa, M. & Taxis, K., May-2023, In: Research in Social and Administrative Pharmacy. 19, 5, 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus
Zhang, F., de Bock, G. H., Denig, P., Landman, G. W., Zhang, Q. & Sidorenkov, G., 24-Jan-2023, In: Clinical epidemiology. 15, p. 109-121 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care
Ambrož, M., Geelink, M., Smits, K. P. J., de Vries, S. T. & Denig, P., Jan-2023, In: Diabetic Medicine. 40, 1, 10 p., e14987.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)7 Downloads (Pure) -
Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study
Abou, J., Crutzen, S., Tromp, V., Heringa, M., Van Marum, R., Elders, P., Taxis, K., Denig, P. & Hugtenburg, J., Mar-2022, In: Drugs & Aging. 39, 3, p. 209-221 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Citations (Scopus)25 Downloads (Pure)
Activities
-
Deprescribing in de praktijk: belemmerende en bevorderende factoren bij artsen en patiënten.
Petra Denig (Invited speaker)
6-Apr-2022Activity: Talk and presentation › Professional or public presentation › Professional
-
38th ICPE International Conference on Pharmacoepidemiology
Petra Denig (Contributor)
2022Activity: Organising and attending an event › Organising and contributing to an event › Academic
-
Getting deprescribing into clinical practice: Deprescribing guidelines
Petra Denig (Invited speaker)
6-Sept-2022 → 7-Sept-2022Activity: Talk and presentation › Academic presentation › Academic
-
Northern European Researchers in Deprescribing (NERD) (External organisation)
Petra Denig (Member of board)
2022 → …Activity: Membership › Academic
-
Verbeteren van geneesmiddelgebruik: hoe maken we het meetbaar?
Petra Denig (Keynote speaker)
19-May-2022Activity: Talk and presentation › Professional or public presentation › Professional
Datasets
-
Quality assessment of pharmacotherapy in patients with chronic kidney disease in secondary care patients
Denig, P. (Contributor), University of Groningen, 1-Jan-2019
DOI: 10.34760/5f5b7d5599e14, https://doi.org/10.34760%2F5f5b7d5599e14
Dataset
-
Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients
Vries ,de, D. (Contributor), Voorham, J. (Contributor), Hak, E. (Contributor) & Denig, P. (Contributor), figshare, 25-Nov-2015
DOI: 10.6084/m9.figshare.1579453.v1, https://figshare.com/articles/Adherence_to_standard_dose_or_low_dose_statin_treatment_and_low_density_lipoprotein_cholesterol_response_in_type_2_diabetes_patients/1579453/1
Dataset
-
Quality assessment of pharmacotherapy in patients with chronic kidney disease: development of indicators
Denig, P. (Contributor), University of Groningen, 1-Jan-2019
Dataset
-
GIANTT Groningen Initiative to ANalyse Type 2 diabetes Treatment
Denig, P. (Creator), Universitair Medisch Centrum Groningen / Rijksuniversiteit Groningen, 1-Jan-2007
http://www.giantt.nl and one more link, http://www.giantt.nl/enoutline.htm (show fewer)
Dataset
-
Gender differences in adverse drug reactions: knowledge synthesis and exploration
de Vries, S. (Contributor), Denig, P. (Contributor), Burgers, J. S. (Contributor), Kleefstra, N. (Contributor), Mol, P. G. (Contributor) & van Puijenbroek, E. (Contributor), University of Groningen, 2-Aug-2019
DOI: 10.34894/q0xnjs, https://doi.org/10.34894%2Fq0xnjs
Dataset
Press/Media
-
Minderen en stoppen van medicatie
19/07/2021
1 Media contribution
Press/Media: Public Engagement Activities › Popular
-
Interview Farma Magazine
Martina Ambroz, Sieta de Vries, Klaas Hoogenberg & Petra Denig
18/02/2021
1 item of Media coverage
Press/Media: Public Engagement Activities › Professional
-
Waarom pillen steeds beter werken [Dagblad van het Noorden]
Job Boven, van, Jos Kosterink & Petra Denig
07/03/2020
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Deprescribing: hoe minder, hoe beter
01/11/2019
1 Media contribution
Press/Media: Public Engagement Activities › Professional
-
Verschillen in bijwerkingen bij man en vrouw onder de loep
14/04/2017
1 item of Media coverage
Press/Media: Research › Popular
Prizes
-
Top 10% most cited in 2021 PlosOne papers published in 2019
Denig, Petra (Recipient), 2021
Prize › Academic
-
Among the most popular scientific papers in Drug Safety 2019
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2019
Prize: Other distinction › Academic
-
-
Nomination of Top downloaded paper 2018-2019 in BJCP
de Vries, Sieta (Recipient), Denig, Petra (Recipient), Mol, Peter (Recipient) & van Puijenbroek, Eugène (Recipient), 30-Apr-2019
Prize: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2018
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2018
Prize: Other distinction › Academic